We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Most cancer tissues showed weak to moderate cytoplasmic immunoreactivity, often with a granular pattern. Few prostate cancers were strongly stained. Lymphomas, testicular cancers, squamous and basal cell carcinomas along with several melanomas, liver, renal and stomach cancers were negative.
Cancer tissues displayed moderate to strong cytoplasmic staining. Most of the gliomas, lymphomas, skin, testicular, urothelial, renal, endometrial and cervical cancers were weakly stained or negative.
Most cancer tissues showed moderate cytoplasmic positivity. Cases of prostate, endometrial, breast, liver and urothelial cancers showed strong cytoplasmic immunoreactivity.
GENE INFORMATION
Gene name
IDUA (HGNC Symbol)
Synonyms
MPS1
Description
Iduronidase, alpha-L- (HGNC Symbol)
Entrez gene summary
This gene encodes an enzyme that hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. This hydrolysis is required for the lysosomal degradation of these glycosaminoglycans. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I). [provided by RefSeq, Jul 2008]
Enzymes ENZYME proteins Hydrolases Predicted secreted proteins Secreted proteins predicted by MDSEC SignalP predicted secreted proteins Phobius predicted secreted proteins SPOCTOPUS predicted secreted proteins Plasma proteins Disease related genes Potential drug targets Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)
